Integrative genomic profiling of human prostate cancer
- PMID: 20579941
- PMCID: PMC3198787
- DOI: 10.1016/j.ccr.2010.05.026
Integrative genomic profiling of human prostate cancer
Abstract
Annotation of prostate cancer genomes provides a foundation for discoveries that can impact disease understanding and treatment. Concordant assessment of DNA copy number, mRNA expression, and focused exon resequencing in 218 prostate cancer tumors identified the nuclear receptor coactivator NCOA2 as an oncogene in approximately 11% of tumors. Additionally, the androgen-driven TMPRSS2-ERG fusion was associated with a previously unrecognized, prostate-specific deletion at chromosome 3p14 that implicates FOXP1, RYBP, and SHQ1 as potential cooperative tumor suppressors. DNA copy-number data from primary tumors revealed that copy-number alterations robustly define clusters of low- and high-risk disease beyond that achieved by Gleason score. The genomic and clinical outcome data from these patients are now made available as a public resource.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198787/bin/nihms271566f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198787/bin/nihms271566f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198787/bin/nihms271566f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3198787/bin/nihms271566f4.gif)
Comment in
-
New views into the prostate cancer genome.Cancer Cell. 2010 Jul 13;18(1):1-2. doi: 10.1016/j.ccr.2010.06.011. Cancer Cell. 2010. PMID: 20609345
Similar articles
-
Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers.J Pathol. 2013 Sep;231(1):130-41. doi: 10.1002/path.4223. J Pathol. 2013. PMID: 23794398
-
Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer.Cancer Res. 2009 Oct 1;69(19):7793-802. doi: 10.1158/0008-5472.CAN-08-3810. Epub 2009 Sep 22. Cancer Res. 2009. PMID: 19773449 Free PMC article.
-
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer.Cancer Res. 2006 Nov 15;66(22):10658-63. doi: 10.1158/0008-5472.CAN-06-1871. Cancer Res. 2006. PMID: 17108102
-
Increased androgen receptor gene copy number is associated with TMPRSS2-ERG rearrangement in prostatic small cell carcinoma.Mol Carcinog. 2015 Sep;54(9):900-7. doi: 10.1002/mc.22162. Epub 2014 Apr 29. Mol Carcinog. 2015. PMID: 24777847
-
The prognostic and predictive value of TMPRSS2-ERG gene fusion and ERG protein expression in prostate cancer biopsies.Dan Med J. 2016 Dec;63(12):B5319. Dan Med J. 2016. PMID: 27910803 Review.
Cited by
-
WNT1-inducible signaling pathway protein 1 activation through C-X-C motif chemokine ligand 5/C-X-C chemokine receptor type 2/leukemia inhibitory factor/leukemia inhibitory factor receptor signaling promotes immunosuppression and neuroendocrine differentiation in prostate cancer.iScience. 2024 Jul 20;27(8):110562. doi: 10.1016/j.isci.2024.110562. eCollection 2024 Aug 16. iScience. 2024. PMID: 39175775 Free PMC article.
-
Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer.World J Urol. 2024 Aug 22;42(1):491. doi: 10.1007/s00345-024-05188-7. World J Urol. 2024. PMID: 39172235 Free PMC article.
-
FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells.Commun Biol. 2024 Aug 17;7(1):1011. doi: 10.1038/s42003-024-06704-6. Commun Biol. 2024. PMID: 39154074 Free PMC article.
-
The extracellular matrix component perlecan/HSPG2 regulates radioresistance in prostate cancer cells.Front Cell Dev Biol. 2024 Aug 1;12:1452463. doi: 10.3389/fcell.2024.1452463. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39149513 Free PMC article.
References
-
- Agoulnik IU, Vaid A, Bingman WE, 3rd, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL. Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res. 2005;65:7959–7967. - PubMed
-
- Arber S. FoxP1: conducting the Hox symphony in spinal motor neurons. Nat Neurosci. 2008;11:1122–1124. - PubMed
-
- Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 1995;57
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical